A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome
Clinical trial NCT04251026 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04251026
- Sponsor
- Denali Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2031-02-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.